Treating disorders by application of insulin-like growth factor

Details Treating disorders by application of insulin-like growth factor Treating disorders by application of insulin-like growth factor

1989-06-05

1992-03-03

Moezie, F. T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 3, 514 4, 514885, 514903, 514 21, 424556, 424570, A61K 3736, A61K 3726

Patent

active

050933175

ABSTRACT:
Method of enhancing the survival of neuronal cells, more preferably non-mitotic neuronal cells and/or cholinergic cells in a mammal, which cells are at risk of dying, which method includes administering to the mammal an effective amount of a functional derivative of Insulin-like Growth Factor I or Insulin-like Growth Factor II.

REFERENCES:
patent: 4341762 (1982-07-01), Haast
patent: 4511390 (1985-04-01), Kauer
patent: 4699875 (1987-10-01), Appel
patent: 4783524 (1988-11-01), Larsen et al.
patent: 4801575 (1989-01-01), Pardridge
Baxter et al., Comp. Biochem. Physiol. 91B:229-235 (1988).
Daughaday et al., Endocrine Rev. 10:68-91 (1989).
D'Ercole, J. Devel. Physiol. 9:481-495 (1987).
Hintz et al., Horm. Metab. Res. 20:344-347 (1988).
Baskin et al., TINS 11:107-111 (1988).
Sara et al., Proc. Natl. Acad. Sci. USA 83:4904-4907 (1986).
Francis et al., Biochem. J. 251:95-103 (1988).
Sara et al., Neurosci. Let. 34:39-44 (1982).
Aizenman et al., Brain Res. 406:32-42 (1987).
Fellows et al., Soc. Neurosci. Abstr. 13:1615 (1987).
Onifer et al., Soc. Neurosci. Abstr. 13:1615 (1987).
Bothwell, J. Neurosci. Res. 8:225-231 (1982).
Recio-Pinto et al., J. Neurosci. 6:1211-1219 (1986).
Recio-Pinto and Ishii, J. Neurosci. Res. 19:312-320 (1988).
Mattson et al., J. Cell Biol. 102:1949-54 (1986).
Sara et al., J. Dev. Physiol. 1:343-350 (1979).
Sara et al., Prog. Brain Res. 73:87-99 (1988).
Sara et al., Neurobiol. Aging 3:117-120 (1982).
Nilsson et al., Neurosci. Let. 88:221-226 (1988).
Hansson et al., Acta Physiol. Scand. 132:35-41 (1988).
Sjoberg et al., Brain Res. 485:102-108 (1989).
Coy et al., Biochem. Biophys. Res. Commun. 73:632-8 (1976).
Pardridge, Endocrine Reviews 7:314-330 (1986).
Blundell et al., Fed. Proc. 42:2592-2597 (1983).
Kastin et al., Pharmac. Biochem. Behav. 11:713-716 (1979).
Rapoport et al., Science 207:84-86 (1980).
Pardridge et al., Biochem. Biophys. Res. Commun. 146:307-313 (1987).
Riekkinen et al., Peptides 8:261-265 (1987).
Creveling et al., Experientia 25:26-27 (1969).
Bodor et al., Science 214:1370-1372 (1981).
Smith et al., Pharm Res. (in press).
McManaman et al., Dev. Biol. 112:248-252 (1985).
Schwartz et al., Dev. Brain Res. 1:403-413 (1981).
Kanje et al., Brain Res. 381:24-28 (1986).
Hansson et al. Act & Physiol. Scand. 126:609-614 (1986).
Sara et al. Biol. Psychiat. 18:803-811 (1983).
MacDonnell et al., Proc. Natl. Acad. Sci. USA 74:4681-4684 (1977).
Schwartz et al., Archives of Biochemistry & Biophysics 181:542-549 (1977).
Hintz et al., J. Clinical Endocrinology and Metabolism 54:442-446.
Russell et al., Life Sciences 19:1297-1306 (1976).
Rinehart et al., Proc. Natl. Acad. Sci. USA 82:4365-4368 (1985).

Affiliated with

Also associated with

Rating

Treating disorders by application of insulin-like growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating disorders by application of insulin-like growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating disorders by application of insulin-like growth factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-272239